The US Food and Drug Administration issues a recall affecting more than 3,700 bottles of blood pressure medication that it says are ineffective. The recall applies nationwide, according to one report, and is tied to product quality issues that prevent the medicine from meeting required performance standards.

Both outlets describe the FDA as the source of the recall notice, but they emphasize slightly different details. The Washington Times highlights that the bottles are “deemed ineffective.” The New York Post focuses on how the issue is identified through testing, describing the FDA’s stated reason as “failed dissolution specifications,” indicating the pills do not dissolve as expected under quality checks. Taken together, the reports frame the recall as a manufacturing or quality control problem that affects whether the medication is expected to work as intended.